Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes

Annals of the New York Academy of Sciences

Volumn 921, Issue , 2000, Pages 45-54

  Lara Marquez, Maria L ^a   O'dorisio, M Sue ^b   Karacay, Bahri ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

BINDING SITE; CELL STIMULATION; CELL SUBPOPULATION; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T LYMPHOCYTE ACTIVATION; THYMOCYTE;

EID: 0034500696     PISSN: 00778923     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1749-6632.2000.tb06950.x     Document Type: Article

References (10)

1. Lymphoid tissues and organs
2. Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs
3. High gradient magnetic cell separation with MACS
4. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 mononclonal antibody
5. Real time quantitative PCR
6. Differential VIP and VIP1 receptor gene expression in rat thymocyte subsets
7. Vasoactive intestinal peptide in thymus: Synthesis, receptors and biological actions
8. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients
9. Molecular cloning of a novel transcriptional repressor protein of the rat type 1 vasoactive intestinal peptide receptor gene